Input: Article: One result of debates over the meaning and validity of the concept of race is that the current literature across different disciplines regarding human variation lacks consensus, though within some fields, such as some branches of anthropology, there is strong consensus. Some studies use the word race in its early essentialist taxonomic sense. Many others still use the term race, but use it to mean a population, clade, or haplogroup. Others eschew the concept of race altogether, and use the concept of population as a less problematic unit of analysis.

Now answer this question: What does the current literature regarding human variation lack?

Output: consensus

Input: Article: The managing director of London Weekend Television (LWT), Greg Dyke, met with the representatives of the "big five" football clubs in England in 1990. The meeting was to pave the way for a break away from The Football League. Dyke believed that it would be more lucrative for LWT if only the larger clubs in the country were featured on national television and wanted to establish whether the clubs would be interested in a larger share of television rights money. The five clubs decided it was a good idea and decided to press ahead with it; however, the league would have no credibility without the backing of The Football Association and so David Dein of Arsenal held talks to see whether the FA were receptive to the idea. The FA did not enjoy an amicable relationship with the Football League at the time and considered it as a way to weaken the Football League's position.

Now answer this question: Did the five clubs think this was a good idea?

Output: The five clubs decided it was a good idea and decided to press ahead with it

Input: Article: Drug discovery and development is very expensive; of all compounds investigated for use in humans only a small fraction are eventually approved in most nations by government appointed medical institutions or boards, who have to approve new drugs before they can be marketed in those countries. In 2010 18 NMEs (New Molecular Entities) were approved and three biologics by the FDA, or 21 in total, which is down from 26 in 2009 and 24 in 2008. On the other hand, there were only 18 approvals in total in 2007 and 22 back in 2006. Since 2001, the Center for Drug Evaluation and Research has averaged 22.9 approvals a year. This approval comes only after heavy investment in pre-clinical development and clinical trials, as well as a commitment to ongoing safety monitoring. Drugs which fail part-way through this process often incur large costs, while generating no revenue in return. If the cost of these failed drugs is taken into account, the cost of developing a successful new drug (new chemical entity, or NCE), has been estimated at about 1.3 billion USD(not including marketing expenses). Professors Light and Lexchin reported in 2012, however, that the rate of approval for new drugs has been a relatively stable average rate of 15 to 25 for decades.

Now answer this question: What does NMEs stand for?

Output:
New Molecular Entities